BMEA: Biomea Fusion, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 236.64
Enterprise Value ($M) 148.69
Book Value ($M) 75.97
Book Value / Share 2.10
Price / Book 3.11
NCAV ($M) 59.15
NCAV / Share 1.63
Price / NCAV 4.00

Profitability (mra)
Return on Invested Capital (ROIC) -1.68
Return on Assets (ROA) -0.64
Return on Equity (ROE) -0.72

Liquidity (mrq)
Quick Ratio 3.39
Current Ratio 3.39

Balance Sheet (mrq) ($M)
Current Assets 93.60
Assets 110.42
Liabilities 34.45
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
7 days ago 13G/A Laurion Capital Management LP 0.00 -100.00
07-10 13G/A State Street Corp 1.88 -84.94
02-14 13G/A Baker Bros. Advisors Lp 5.90 0.21
02-12 13G/A Janus Henderson Group Plc 4.80 -37.68
02-12 13G/A Butler Thomas Andrew 10.40 10.13
02-12 13G/A Erdtmann Rainer M 7.80 4.21
02-09 13G/A Fmr Llc 15.00 7.23
01-29 13G BlackRock, Inc. 6.00 148.71

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-10-29 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-07-31 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-18 199,714 781,271 25.56
2024-11-15 184,071 849,563 21.67
2024-11-14 144,912 541,763 26.75
2024-11-13 212,182 1,007,221 21.07

(click for more detail)

Similar Companies
BEAM – Beam Therapeutics Inc. BIIB – Biogen Inc.
BLUE – bluebird bio, Inc. BMRN – BioMarin Pharmaceutical Inc.
BOLT – Bolt Biotherapeutics, Inc.


Financial data and stock pages provided by
Fintel.io